Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

BioInvent International AB

+ Add to Watchlist

BINVBTA:SS

2.2300 SEK 0.0400 1.76%

As of 05:12:23 ET on 05/28/2015.

Snapshot for BioInvent International AB (BINVBTA)

Open: 2.2000 Day's Range: 2.2000 - 2.2300 Volume: 5,000
Previous Close: 2.2700 52wk Range: 1.8000 - 2.2800 1-Yr Rtn: -

Stock Chart for BINVBTA

No chart data available.
  • BINVBTA:SS 2.2300
  • 1D
  • 1M
  • 1Y
2.2700
Interactive BINVBTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BINVBTA

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. OMX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 478.79
Shares Outstanding (M) 50.13
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/22/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BINVBTA

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for BINVBTA

BioInvent International AB is a research and development company within biotechnology. The Company has created human antibody libraries that can be used in a broad range of applications. BioInvent delivers proteins to drug and biotechnology companies, grants licenses for use of its libraries, and establishes partnerships to develop and manufacture protein based drugs.

Michael S OredssonPresident/CEOPer-Anders JohanssonSenior VP:Tech Operations
Martin WilesSenior VP:Business DevelopmentBjoern FrendeusVP:Preclinical Research
More Company Profile & Key Executives for BINVBTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil